ENVB
Enveric Biosciences, Inc.
Company overview
- Market capitalization
- $5.41M
- Employees
- 5
- Latest publication
- 2026-09-29
About Enveric Biosciences, Inc.
Enveric Biosciences, Inc., a biotechnology company, focuses on the development of small molecule neuroplastogenic therapeutics that address unmet needs in psychiatric and neurological disorders in the United States. Its lead drug candidate is EB-003, a novel derivative of DMT in preclinical development for mental health indications. The company also develops EVM401 series comprising novel phenylalkylamines and indolethylamines, as well as mescaline-derived compounds to target addiction and neuropsychiatric disorders; and Psybrary, a proprietary library. Enveric Biosciences, Inc. is headquartered in Cambridge, Massachusetts.
Financial statements
Income Quarterly
| Metric | Q1 20262026-03-31 · USD | Q4 20252025-12-31 · USD | Q3 20252025-09-30 · USD | Q2 20252025-06-30 · USD | Q1 20252025-03-31 · USD | Q4 20242024-12-31 · USD | Q3 20242024-09-30 · USD | Q2 20242024-06-30 · USD |
|---|---|---|---|---|---|---|---|---|
| Net Income | -1,600,000USD | -4,000,000USD | -3,400,000USD | -2,500,000USD | -2,500,000USD | -3,200,000USD | -2,800,000USD | -1,879,394USD |
| Total Revenue | — | — | — | — | — | — | — | 0USD |
| Cost Of Revenue | — | — | — | — | — | — | — | 84,779USD |
| Gross Profit | — | — | — | — | — | — | — | -84,779USD |
| Research Development | — | — | — | — | — | — | — | 515,501USD |
| Selling General Administrative | — | — | — | — | — | — | — | 1,297,651USD |
| Total Operating Expenses | — | — | — | — | — | — | — | 1,813,152USD |
| Operating Income | — | — | — | — | — | — | — | -1,897,931USD |
| Interest Expense | — | — | — | — | — | — | — | 35USD |
| Net Interest Income | — | — | — | — | — | — | — | -35USD |
| Income Before Tax | — | — | — | — | — | — | — | -1,879,394USD |
| Income Tax Expense | — | — | — | — | — | — | — | 1USD |
| Tax Provision | — | — | — | — | — | — | — | 0USD |
| Net Income From Continuing Ops | — | — | — | — | — | — | — | -1,879,394USD |
| Ebit | — | — | — | — | — | — | — | -1,879,389USD |
| Ebitda | — | — | — | — | — | — | — | -1,794,610USD |
| Depreciation And Amortization | — | — | — | — | — | — | — | 84,779USD |
| Reconciled Depreciation | — | — | — | — | — | — | — | 84,779USD |
| Total Other Income Expense Net | — | — | — | — | — | — | — | 18,537USD |
| Minority Interest | — | — | — | — | — | — | — | 0USD |
| Source | DisclosurePreliminary | DisclosurePreliminary | DisclosurePreliminary | DisclosurePreliminary | DisclosurePreliminary | DisclosurePreliminary | DisclosurePreliminary | Legacy providerLegacy |
Income Yearly
| Metric | FY 20252025-12-31 · USD | FY 20242024-12-31 · USD | FY 20232023-12-31 · USD | FY 20222022-12-31 · USD | FY 20212021-12-31 · USD | FY 20202020-12-31 · USD | FY 20192019-12-31 · USD | FY 20182018-12-31 · USD |
|---|---|---|---|---|---|---|---|---|
| Total Revenue | 0USD | 0USD | 0USD | 0USD | 0USD | 39,914,675USD | 39,914,675USD | 42,998,280USD |
| Cost Of Revenue | 200,858USD | 337,489USD | 408,030USD | 435,201USD | 681,612USD | 120,872USD | 31,763,955USD | 34,014,776USD |
| Gross Profit | -200,858USD | -337,489USD | -408,030USD | -435,201USD | -681,612USD | -120,872USD | 8,150,720USD | 8,983,504USD |
| Research Development | 2,781,017USD | 2,841,272USD | 7,252,437USD | 8,027,773USD | 4,788,807USD | 174,083USD | — | — |
| Selling General Administrative | 5,792,573USD | 6,453,505USD | 8,852,021USD | 11,605,761USD | 20,499,052USD | 5,443,234USD | 2,296,534USD | 10,794,822USD |
| Total Operating Expenses | 8,573,590USD | 9,294,777USD | 16,040,410USD | 19,526,243USD | 25,262,890USD | 5,496,445USD | 14,475,614USD | 13,698,484USD |
| Operating Income | -8,774,448USD | -9,632,266USD | -16,448,440USD | -19,961,444USD | -25,944,502USD | -5,617,317USD | -6,324,894USD | -7,146,460USD |
| Interest Expense | 106USD | — | 3,708USD | 5,249USD | 10,316USD | 445,250USD | 691,138USD | 729,896USD |
| Net Interest Income | -106USD | 219USD | 3,007USD | -5,249USD | -10,316USD | -445,250USD | -691,138USD | -729,896USD |
| Income Before Tax | -8,771,987USD | -9,566,057USD | -17,262,819USD | -19,957,393USD | -56,431,701USD | -6,864,676USD | -5,215,318USD | -10,549,014USD |
| Income Tax Expense | 3,359,485USD | 8,930USD | 28,913USD | -1,486,060USD | -7,454,805USD | -477,731USD | 388,657USD | 6,348,502USD |
| Tax Provision | 0USD | 8,930USD | -1,479,465USD | -1,486,060USD | -7,454,805USD | 415,865USD | 388,657USD | 6,348,502USD |
| Net Income | -12,131,472USD | -9,574,987USD | -17,292USD | -18,504,347USD | -48,976,896USD | -6,864,676USD | -5,603,975USD | -16,897,516USD |
| Net Income From Continuing Ops | -8,771,987USD | -9,574,987USD | -22,533,698USD | -18,471,333USD | -48,976,896USD | -6,864,676USD | -5,603,975USD | -16,897,516USD |
| Ebit | -8,772,093USD | -9,566,057USD | -17,262,819USD | -19,952,144USD | -56,421,385USD | -6,419,427USD | -4,524,180USD | -9,819,119USD |
| Ebitda | -8,571,235USD | -9,228,568USD | -16,854,789USD | -19,516,943USD | -55,739,773USD | -6,298,555USD | -2,258,883USD | -6,915,457USD |
| Depreciation And Amortization | 200,858USD | 337,489USD | 408,030USD | 435,201USD | 681,612USD | 120,872USD | 2,265,297USD | 2,903,662USD |
| Reconciled Depreciation | 200,858USD | 337,489USD | 413,969USD | 435,201USD | 681,612USD | 120,872USD | 2,265,297USD | 2,903,662USD |
| Total Other Income Expense Net | 2,461USD | 66,209USD | -814,379USD | 4,051USD | -30,487,199USD | -1,247,359USD | 1,109,576USD | -10,547,094USD |
| Interest Income | — | 219USD | 3,708USD | — | — | — | — | — |
| Minority Interest | — | 0USD | -31,644USD | -33,014USD | 0USD | — | — | — |
| Selling And Marketing Expenses | — | — | 64,048USD | — | — | — | 9,913,783USD | — |
| Net Income Applicable To Common Shares | — | — | — | — | -48,976,896USD | -6,864,676USD | -2,410,673USD | -1,919,577USD |
| Unclassified Operating Expenses | — | — | — | — | — | — | 2,265,297USD | 2,903,662USD |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Balance sheet Quarterly
| Metric | Q2 20262026-06-30 · USD | Q1 20262026-03-31 · USD | Q4 20252025-12-31 · USD | Q3 20252025-09-30 · USD | Q2 20252025-06-30 · USD | Q1 20252025-03-31 · USD | Q4 20242024-12-31 · USD | Q3 20242024-09-30 · USD |
|---|---|---|---|---|---|---|---|---|
| Total Assets | 8,943,999USD | 5,521,464USD | 5,095,941USD | 4,362,061USD | 3,548,454USD | 5,102,119USD | 3,082,543USD | 4,790,316USD |
| Total Current Assets | 8,793,325USD | 5,375,099USD | 4,936,707USD | 4,165,540USD | 3,307,372USD | 4,834,840USD | 2,734,584USD | 4,338,259USD |
| Other Current Assets | 497,029USD | 466,330USD | 259,216USD | 407,946USD | 457,556USD | 540,405USD | 493,558USD | 1,226,576USD |
| Total Liabilities | 861,475USD | 460,676USD | 918,400USD | 905,885USD | 1,363,685USD | 1,184,406USD | 1,489,736USD | 839,166USD |
| Total Current Liabilities | 861,475USD | 460,676USD | 918,400USD | 905,885USD | 1,363,685USD | 1,184,406USD | 1,489,736USD | 839,166USD |
| Other Current Liabilities | 151,931USD | 180,361USD | 99,875USD | 222,178USD | 222,843USD | 413,837USD | 732,010USD | 4,944USD |
| Total Stockholder Equity | 8,082,524USD | 5,060,788USD | 4,177,541USD | 3,456,176USD | 2,184,769USD | 3,917,713USD | 1,592,807USD | 3,951,150USD |
| Total Equity Including Noncontrolling Interest | 8,082,524USD | 5,060,788USD | 4,177,541USD | 3,456,176USD | 2,184,769USD | 3,917,713USD | 1,592,807USD | 3,951,150USD |
| Property Plant Equipment Net | 81,929USD | 119,927USD | 159,234USD | 196,521USD | 241,082USD | 267,279USD | 305,777USD | 367,689USD |
| Accounts Payable | 682,794USD | 280,315USD | 581,020USD | 683,707USD | 1,040,967USD | 669,194USD | 521,747USD | 576,324USD |
| Common Stock | 39,358USD | 18,875USD | 10,615USD | 5,183USD | 30,260USD | 24,716USD | 6,780USD | 89,949USD |
| Retained Earnings | -119,507,698USD | -116,479,965USD | -114,846,492USD | -112,652,321USD | -110,778,652USD | -108,259,471USD | -106,074,505USD | -102,919,859USD |
| Accumulated Other Comprehensive Income | -594,681USD | -587,056USD | -580,038USD | -580,945USD | -573,531USD | -598,004USD | -594,517USD | -534,998USD |
| Source | DisclosureDeterministicFinal | DisclosureDeterministicFinal | DisclosureDeterministicFinal | DisclosureDeterministicFinal | DisclosureDeterministicFinal | DisclosureDeterministicFinal | DisclosureDeterministicFinal | DisclosureDeterministicFinal |
Balance sheet Yearly
| Metric | FY 20252025-12-31 · USD | FY 20242024-12-31 · USD | FY 20232023-12-31 · USD | FY 20222022-12-31 · USD | FY 20212021-12-31 · USD | FY 20202020-12-31 · USD | FY 20192019-12-31 · USD | FY 20182018-12-31 · USD |
|---|---|---|---|---|---|---|---|---|
| Total Assets | 5,095,941USD | 3,082,543USD | 4,299,840USD | 19,552,925USD | 26,719,132USD | 4,096,891USD | 25,005,152USD | 29,637,450USD |
| Total Current Assets | 4,936,707USD | 2,734,584USD | 3,581,531USD | 18,431,937USD | 17,736,837USD | 2,279,170USD | 7,599,154USD | 10,061,353USD |
| Other Current Assets | 259,216USD | 493,558USD | 1,068,947USD | 708,053USD | 380,838USD | 700,710USD | 783,606USD | 818,600USD |
| Total Liabilities | 918,400USD | 1,489,736USD | — | — | — | — | — | — |
| Total Current Liabilities | 918,400USD | 1,489,736USD | 2,343,504USD | 3,995,973USD | 2,083,556USD | 681,250USD | 14,383,605USD | 14,688,965USD |
| Other Current Liabilities | 99,875USD | 732,010USD | — | — | — | — | — | — |
| Total Stockholder Equity | 4,177,541USD | 1,592,807USD | 1,956,336USD | 15,556,952USD | 22,305,919USD | 3,415,641USD | 10,621,547USD | 10,759,097USD |
| Total Equity Including Noncontrolling Interest | 4,177,541USD | 1,592,807USD | — | — | — | — | — | — |
| Property Plant Equipment Net | 159,234USD | 305,777USD | 507,377USD | 741,302USD | 470,734USD | 83,128USD | 83,128USD | 58,892USD |
| Accounts Payable | 581,020USD | 521,747USD | 1,218,783USD | 463,275USD | 683,393USD | 681,250USD | 4,696,352USD | 4,377,794USD |
| Common Stock | 10,615USD | 6,780USD | 27,392USD | 20,782USD | 6,519USD | 100,951USD | 25,221USD | 423,290USD |
| Retained Earnings | -114,846,492USD | -106,074,505USD | -96,499,518USD | -79,207,786USD | -60,736,452USD | -11,759,557USD | -40,508,231USD | -34,478,253USD |
| Accumulated Other Comprehensive Income | -580,038USD | -594,517USD | -569,749USD | -536,734USD | -30,802USD | -181,277USD | 60,012USD | 86,997USD |
| Intangible Assets | — | — | 210,932USD | 379,686USD | 6,923,928USD | 1,817,721USD | 3,584,221USD | 5,778,036USD |
| Total Liab | — | — | 2,343,504USD | 3,995,973USD | 4,413,213USD | 681,250USD | 14,383,605USD | 18,878,353USD |
| Other Current Liab | — | — | 1,102,403USD | 3,468,878USD | 1,292,721USD | 681,250USD | 4,157,732USD | 4,921,742USD |
| Capital Stock | — | — | 27,392USD | 20,782USD | 325,785USD | 133,705USD | 29,470USD | 427,497USD |
| Other Assets | — | — | 1USD | — | — | — | — | — |
| Cash | — | — | 2,287,977USD | 17,723,884USD | 17,355,999USD | 1,578,460USD | 431,400USD | 1,371,331USD |
| Cash And Short Term Investments | — | — | 2,287,977USD | 17,723,884USD | 17,355,999USD | 1,578,460USD | 431,400USD | 1,371,331USD |
| Net Debt | — | — | -2,287,977USD | -17,660,064USD | -17,179,696USD | -1,578,460USD | 4,449,661USD | 3,835,800USD |
| Net Receivables | — | — | 224,607USD | — | — | 6,384,148USD | 6,384,148USD | 7,871,422USD |
| Property Plant Equipment Gross | — | — | 865,088USD | 920,077USD | 498,079USD | 83,128USD | 83,128USD | 58,892USD |
| Common Stock Shares Outstanding | — | — | 11,995shares | 8,033shares | 2,624shares | 639shares | 587shares | 396shares |
| Non Current Assets Total | — | — | 718,309USD | 1,120,988USD | 8,982,296USD | 1,817,721USD | 17,405,998USD | 19,576,097USD |
| Non Current Liabilities Total | — | — | 0USD | 0USD | 2,329,657USD | 0USD | 9,577,413USD | 4,189,388USD |
| Non Currrent Assets Other | — | — | 567,603USD | 0USD | 0USD | 0USD | — | — |
| Net Working Capital | — | — | 1,238,027USD | 14,435,964USD | 15,653,281USD | 1,597,920USD | -6,784,451USD | -4,627,612USD |
| Unclassified Equity | — | — | 98,970,819USD | 95,259,908USD | 82,740,869USD | 15,121,819USD | 51,015,075USD | 44,299,566USD |
| Good Will | — | — | — | 0USD | 1,587,634USD | 13,729,770USD | 13,729,770USD | 13,729,770USD |
| Short Term Debt | — | — | — | 63,820USD | 107,442USD | 4,881,061USD | 4,881,061USD | 5,207,131USD |
| Short Long Term Debt Total | — | — | — | 63,820USD | 176,303USD | 4,881,061USD | 4,881,061USD | 5,207,131USD |
| Other Liab | — | — | — | — | 2,260,796USD | — | — | — |
| Net Tangible Assets | — | — | — | — | 13,794,358USD | 1,565,166USD | -1,814,226USD | -65,454USD |
| Unclassified Current Assets | — | — | — | — | — | -6,384,148USD | — | — |
| Unclassified Non Current Assets | — | — | — | — | — | -13,812,898USD | — | — |
| Unclassified Current Liabilities | — | — | — | — | — | -5,562,311USD | -4,232,601USD | -5,024,833USD |
| Short Long Term Debt | — | — | — | — | — | — | 4,881,061USD | 5,207,131USD |
| Unclassified Non Current Liabilities | — | — | — | — | — | — | 9,577,413USD | 4,189,388USD |
| Source | DisclosureDeterministicFinal | DisclosureDeterministicFinal | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Cash flow YTD
| Metric | Q2 20262026-06-30 · USD | Q3 20252025-09-30 · USD | Q2 20252025-06-30 · USD | Q3 20242024-09-30 · USD |
|---|---|---|---|---|
| Depreciation | 74,066USD | 161,373USD | 121,004USD | 255,002USD |
| Stock Based Compensation | 213,787USD | 587,089USD | 400,108USD | 1,090,716USD |
| Change To Liabilities | 1,635USD | -295,982USD | -11,300USD | -1,296,907USD |
| Change In Working Capital | -274,497USD | -163,187USD | 36,892USD | -1,300,581USD |
| Operating Cash Flow | -4,701,378USD | -6,356,680USD | -4,281,724USD | -6,414,590USD |
| Financing Cash Flow | 8,348,207USD | 7,890,361USD | 4,898,010USD | 7,210,386USD |
| Effect Of Forex Changes On Cash | -28,024USD | -17,113USD | -7,496USD | 27,910USD |
| Change In Cash | 3,618,805USD | 1,516,568USD | 608,790USD | 823,706USD |
| End Cash Flow | 8,296,296USD | 3,757,594USD | 2,849,816USD | 3,111,683USD |
| Source | DisclosureDeterministicFinal | DisclosureDeterministicFinal | DisclosureDeterministicFinal | DisclosureDeterministicFinal |
Cash flow Quarterly
| Metric | Q1 20262026-03-31 · USD | Q4 20252025-12-31 · USD | Q3 20252025-09-30 · USD | Q2 20252025-06-30 · USD | Q1 20252025-03-31 · USD | Q4 20242024-12-31 · USD | Q3 20242024-09-30 · USD | Q2 20242024-06-30 · USD |
|---|---|---|---|---|---|---|---|---|
| Depreciation | 37,240USD | 39,485USD | 40,369USD | 39,980USD | 81,024USD | 82,487USD | 84,814USD | 84,779USD |
| Stock Based Compensation | 88,673USD | 240,234USD | 186,981USD | 206,260USD | 193,848USD | 471,676USD | 369,614USD | 369,614USD |
| Change To Liabilities | -417,390USD | — | — | — | -301,281USD | — | — | — |
| Change In Working Capital | -669,001USD | 100,136USD | -299,954USD | 382,799USD | -347,407USD | 877,338USD | 701,911USD | -1,445,600USD |
| Operating Cash Flow | -2,256,839USD | — | — | — | -2,391,582USD | — | — | — |
| Financing Cash Flow | 2,503,208USD | — | — | — | 4,448,914USD | — | — | — |
| Effect Of Forex Changes On Cash | -15,091USD | — | — | — | -3,923USD | — | — | — |
| Change In Cash | 231,278USD | 919,897USD | 907,778USD | -1,444,619USD | 2,053,409USD | -870,657USD | -390,868USD | -2,853,485USD |
| End Cash Flow | 4,908,769USD | — | — | — | 4,294,435USD | — | — | — |
| Net Income | — | -2,194,171USD | -1,873,669USD | -2,519,181USD | — | -3,154,646USD | -2,084,032USD | -1,879,394USD |
| Other Non Cash Items | — | 29,453USD | -128,683USD | — | — | 411,596USD | 623USD | -18,572USD |
| Total Cash From Operating Activities | — | -1,784,863USD | -2,074,955USD | -1,890,142USD | — | -1,311,549USD | -927,070USD | -2,889,173USD |
| Capital Expenditures | — | 0USD | -4USD | 0USD | — | 0USD | -3USD | -3USD |
| Free Cash Flow | — | -1,784,863USD | -2,074,960USD | -1,890,142USD | — | -1,311,549USD | -927,070USD | -2,889,173USD |
| Total Cash From Financing Activities | — | 2,689,146USD | 2,992,351USD | 449,096USD | — | 463,448USD | 517,687USD | 34,430USD |
| Dividends Paid | — | -1,846,036USD | -1,513,449USD | — | — | — | — | — |
| Issuance Of Capital Stock | — | 0USD | 1,058,300USD | 449,096USD | — | -1,320,975USD | 517,836USD | 51,684USD |
| Begin Period Cash Flow | — | 3,757,594USD | 2,849,816USD | 4,294,435USD | — | 3,111,683USD | 3,502,551USD | 6,356,036USD |
| End Period Cash Flow | — | 4,677,491USD | 3,757,594USD | 2,849,816USD | — | 2,241,026USD | 3,111,683USD | 3,502,551USD |
| Other Cashflows From Financing Activities | — | 1,846,036USD | 4,505,800USD | — | — | 1,784,423USD | -1,804,968USD | -17,254USD |
| Unclassified Financing Cash Flow | — | 2,689,146USD | -1,058,300USD | — | — | -2,404,681USD | 1,722,793USD | — |
| Investments | — | — | — | — | — | 0USD | 0USD | 0USD |
| Sale Purchase Of Stock | — | — | — | — | — | 1,083,706USD | 599,862USD | — |
| Other Cashflows From Investing Activities | — | — | — | — | — | — | 3USD | — |
| Source | DisclosureDeterministicFinal | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | DisclosureDeterministicFinal | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Cash flow Yearly
| Metric | FY 20252025-12-31 · USD | FY 20242024-12-31 · USD | FY 20232023-12-31 · USD | FY 20222022-12-31 · USD | FY 20212021-12-31 · USD | FY 20202020-12-31 · USD | FY 20192019-12-31 · USD | FY 20182018-12-31 · USD |
|---|---|---|---|---|---|---|---|---|
| Depreciation | 200,858USD | 337,489USD | 408,030USD | 435,201USD | 681,612USD | 120,872USD | 2,265,297USD | 2,903,662USD |
| Stock Based Compensation | 827,323USD | 1,562,392USD | 2,150,160USD | 2,620,671USD | 12,597,000USD | 1,977,155USD | 586,495USD | 1,251,488USD |
| Change To Liabilities | -413,864USD | -834,630USD | — | — | 383,199USD | 267,002USD | 919,968USD | 151,668USD |
| Change In Working Capital | -162,926USD | -656,134USD | -174,750USD | -217,660USD | 1,185,067USD | -369,495USD | 1,024,308USD | -1,028,554USD |
| Operating Cash Flow | -8,141,543USD | -7,726,139USD | — | — | — | — | — | — |
| Financing Cash Flow | 10,579,507USD | 7,673,834USD | — | — | — | — | — | — |
| Effect Of Forex Changes On Cash | -1,499USD | 5,354USD | — | — | — | — | — | — |
| Change In Cash | 2,436,465USD | -46,951USD | -15,435,907USD | 367,885USD | 15,777,539USD | 1,534,746USD | -1,327,617USD | -3,510,753USD |
| End Cash Flow | 4,677,491USD | 2,241,026USD | — | — | — | — | — | — |
| Net Income | — | — | -17,291,732USD | -18,471,333USD | -48,976,896USD | -6,864,676USD | -2,410,673USD | -16,897,516USD |
| Other Non Cash Items | — | — | 813,881USD | -9,300USD | 30,510,350USD | 1,247,359USD | 738,505USD | 4,856,923USD |
| Total Cash From Operating Activities | — | — | -14,094,411USD | -17,146,723USD | -11,457,671USD | -3,888,785USD | -647,860USD | -2,565,495USD |
| Capital Expenditures | — | — | -5,180USD | -584,165USD | -864,719USD | -44,143USD | -84,331USD | -189,719USD |
| Free Cash Flow | — | — | -14,099,591USD | -17,730,888USD | -12,322,390USD | -3,932,928USD | -647,860USD | -2,565,495USD |
| Investments | — | — | 5,512USD | -584,165USD | 2,190,609USD | -44,143USD | -284,331USD | -3,639,246USD |
| Total Cashflows From Investing Activities | — | — | 11,667USD | -584,165USD | 2,190,609USD | -44,143USD | -284,331USD | -3,639,246USD |
| Total Cash From Financing Activities | — | — | -1,343,141USD | 18,180,137USD | 24,899,659USD | 5,531,270USD | 560,000USD | 2,693,988USD |
| Sale Purchase Of Stock | — | — | -1,052,057USD | 0USD | — | — | — | 2,089,151,000,000USD |
| Issuance Of Capital Stock | — | — | -1USD | 17,222,099USD | 21,614,488USD | 488,000USD | 2,123,594USD | 6,327,954USD |
| Begin Period Cash Flow | — | — | 17,723,884USD | 17,356,000USD | 1,578,460USD | 43,714USD | 1,371,331USD | 4,882,084USD |
| End Period Cash Flow | — | — | 2,287,977USD | 17,723,884USD | 17,356,000USD | 1,578,460USD | 43,714USD | 1,371,331USD |
| Other Cashflows From Investing Activities | — | — | 16,847USD | -958,038USD | -675USD | -44USD | — | 6,421USD |
| Other Cashflows From Financing Activities | — | — | -1,343,141USD | 958,038USD | 3,285,171USD | 3,372,500USD | 22,000USD | -1,657,667USD |
| Unclassified Financing Cash Flow | — | — | 1,052,057USD | 17,222,099USD | — | — | -2,145,594USD | 3,791,655USD |
| Unclassified Operating Cash Flow | — | — | — | -1,504,302USD | -7,454,804USD | — | -2,851,792USD | 6,348,502USD |
| Unclassified Investing Cash Flow | — | — | — | 1,542,203USD | — | — | — | — |
| Net Borrowings | — | — | — | — | 0USD | 1,670,770USD | 560,000USD | 560,000USD |
| Change To Account Receivables | — | — | — | — | — | 1,487,274USD | 1,487,274USD | 967,031USD |
| Change To Inventory | — | — | — | — | — | — | -222,679USD | — |
| Dividends Paid | — | — | — | — | — | — | — | -2,089,151,000,000USD |
| Source | DisclosureDeterministicFinal | DisclosureDeterministicFinal | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Operating metrics
No operating metrics are currently published for this company.
Revenue breakdown
No revenue breakdown is currently published for this company.
Periods follow company fiscal calendars. Quarterly, annual and year-to-date amounts are shown separately. Missing values are not zero. Data may be delayed, incomplete or corrected; follow the disclosure links to verify figures.